Trial intelligence / Profile preview

Safety and Efficacy of Moxidex Otic Solution in Acute Otitis Media with Otorrhea

NCT01071902Phase 3Terminated

Sponsor
Alcon Inc.
Start
Feb 2010
Primary completion
Oct 2011
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of moxifloxacin, dexamethasone in acute otitis media (AOM), sponsored by Alcon Inc.. Started Feb 2010; status: terminated.

02

Drugs

moxifloxacindexamethasone
03

Conditions

acute otitis media (AOM)

Beyond the preview

Go deeper on NCT01071902.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01071902.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call